Skip to main content

Development and External Validation of a Detection Model to Retrospectively Identify Patients With Acute Respiratory Distress Syndrome.

Critical care medicine2025-04-08PubMed
Total: 77.0Innovation: 7Impact: 8Rigor: 8Citation: 8

Summary

Using structured EHR data plus radiology reports, a regularized logistic model achieved AUROC 0.91 (internal) and 0.88 (external) with good calibration (ICI 0.13). At a set threshold, sensitivity/specificity were both 80%, PPV 64%, and cases were identified a median 2.2 hours after Berlin criteria, enabling robust retrospective ARDS phenotyping across health systems.

Key Findings

  • Regularized logistic EHR+radiology model achieved AUROC 0.91 (internal) and 0.88 (external), with external ICI 0.13.
  • At a prespecified threshold, sensitivity and specificity were both 80%, with PPV 64%.
  • Model identified ARDS a median 2.2 hours after meeting Berlin criteria, enabling timely retrospective capture.
  • Physician-adjudicated labels and cross-system validation support generalizability.

Clinical Implications

Hospitals and researchers can apply this validated EHR+radiology model to consistently identify ARDS cases for quality improvement, surveillance, and research; prospective adaptation could support earlier recognition and trial enrollment.

Why It Matters

The model standardizes retrospective ARDS identification using routinely collected data and generalizes across systems, enabling reproducible cohort building, quality measurement, and multicenter research.

Limitations

  • Retrospective design; model identifies ARDS shortly after criteria are met rather than predicting pre-onset.
  • External validation limited to two health systems; performance in broader settings and languages requires testing.

Future Directions

Prospective implementation for early ARDS recognition, integration with bedside alerts, and testing across diverse health systems and international datasets.

Study Information

Study Type
Retrospective cohort (machine learning development and validation)
Research Domain
Diagnosis
Evidence Level
III - Retrospective cohort with external validation
Study Design
OTHER